ANRO

Alto Neuroscienc

• Benzinga·10/19 14:37

  HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60

• TipRanks·10/19 13:35

  Alto Neuroscience price target raised to $60 from $55 at H.C. Wainwright

• Seeking Alpha·10/15 17:07

  Alto Neuroscience: Doubts Around Depression Candidate Merit Downgrade To Hold

• TipRanks·10/02 20:50

  Analysts Are Bullish on Top Healthcare Stocks: Alto Neuroscience, Inc. (ANRO), Phreesia (PHR)

• TipRanks·09/23 08:40

  Alto Neuroscience (ANRO) Defendants Move to Dismiss Third Amended Securities Complaint Over Phase 2b Trial Disclosures

• Seeking Alpha·09/17 14:20

  10 small-cap healthcare stocks with the strongest momentum grades

• Seeking Alpha·08/28 14:14

  Alto Neuroscience promotes Nick Smith to president & CFO

• TipRanks·08/27 22:30

  Alto Neuroscience Promotes Smith to President, CFO

• TipRanks·08/27 20:15

  Alto Neuroscience names Nick Smith president, CFO

• Benzinga·08/27 20:09

  Alto Neuroscience Promotes Nick Smith To President, CFO, Effective Aug. 26

• Dow Jones·08/27 20:05

  *Alto Neuroscience Promotes Nick Smith To President And Chief Financial Officer >ANRO

• TipRanks·08/21 19:36

  Alto Neuroscience Lawsuit Dismissed for Now, With Investors Given Chance to Amend Claims

• Dow Jones·08/17 16:21

  Alto Neuroscience Price Target Raised to $55.00/Share From $50.00 by HC Wainwright & Co.

• Dow Jones·08/17 16:21

  Alto Neuroscience Is Maintained at Buy by HC Wainwright & Co.